Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

被引：0
|
作者：
Jose Seijas-Amigo
Mª José Mauriz-Montero
Pedro Suarez-Artime
Mónica Gayoso-Rey
Ana Estany-Gestal
Antonia Casas-Martínez
Lara González-Freire
Ana Rodriguez-Vazquez
Natalia Pérez-Rodriguez
Laura Villaverde-Piñeiro
Concepción Castro-Rubinos
Esther Espino-Faisán
Moisés Rodríguez-Mañero
Alberto Cordero
José R. González-Juanatey
机构：
[1] Complejo Hospitalario Universidad de Santiago de Compostela,Cardiology Department
[2] Universidade de Santiago de Compostela (USC),Pharmacy Department
[3] Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV),Pharmacy Department
[4] Complejo Hospitalario Universitario A Coruña,Pharmacy Department
[5] Complejo Hospitalario Universidad de Santiago de Compostela,Departament of Methodology
[6] Complejo Hospitalario Universitario de Vigo,Pharmacy Department
[7] FIDIS,Pharmacy Department
[8] Complejo Hospitalario Universitario de Ferrol,Pharmacy Department
[9] Complejo Hospitalario Universitario de Pontevedra,Pharmacy Department
[10] Complejo Hospitalario Universitario de Ourense,Pharmacy Department
[11] Complejo Hospitalario Universitario de Lugo,Pharmacy Department
[12] Hospital Comarcal de Monforte,Pharmacy Department
[13] Hospital Público da Mariña,Cardiology Division
[14] Hospital do Barbanza,Unidad de Investigación en Cardiología
[15] Hospital IMED Elche,Pharmacy Department
[16] Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO),undefined
[17] Hospital Virxen da Xunqueira,undefined
来源：
American Journal of Cardiovascular Drugs | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：583 / 593
页数：10
相关论文
共 50 条
  • [1] Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World-MEMOGAL Study
    Seijas-Amigo, Jose
    Jose Mauriz-Montero, Ma
    Suarez-Artime, Pedro
    Gayoso-Rey, Monica
    Estany-Gestal, Ana
    Casas-Martinez, Antonia
    Gonzalez-Freire, Lara
    Rodriguez-Vazquez, Ana
    Perez-Rodriguez, Natalia
    Villaverde-Pineiro, Laura
    Castro-Rubinos, Concepcion
    Espino-Faisan, Esther
    Rodriguez-Manero, Moises
    Cordero, Alberto
    Gonzalez-Juanatey, Jose R.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (05) : 583 - 593
  • [2] ANGIOGENESIS AND THE PROGRESSION OF SUBCLINICAL ATHEROSCLEROSIS: A 24-MONTH FOLLOW-UP STUDY
    Shin, Sanghoon
    Lee, Sang-Hak
    Ko, Young-Guk
    Kang, Seok-Min
    Choi, Donghoon
    Ha, Jong-Won
    Chung, Namsik
    Shim, Won-Heum
    Cho, Seung-Yun
    Jang, Yangsoo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [3] PCSK9 inhibitors associated hyperglycemic disorders: a real world, pharmacovigilance study
    Goldman, A. G.
    Raschi, E. R.
    Cukierman-Yaffe, T. Y.
    Dankner, R. D.
    Shouval, R. S.
    Shechter, M. D.
    Ben-Zvi, I. B. Z.
    Maor, E. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2934 - 2934
  • [4] Clinical results of cervical discectomy and fusion with anchored cage - prospective study with a 24-month follow-up
    Opsenak, R.
    Kolarovszki, B.
    Benco, M.
    Richterova, R.
    Snopko, P.
    Hanko, M.
    Varga, K.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2018, 81 (06) : 669 - 677
  • [5] The trajectory of sleep after critical illness: a 24-month follow-up study
    Henriquez-Beltran, Mario
    Benitez, Ivan D.
    Vaca, Rafaela
    Santisteve, Sally
    Aguila, Maria
    Vila, Anna
    Minguez, Olga
    Rodriguez-Munoz, Carlos
    Galan-Gonzalez, Anna
    Carvalho-Brugger, Sulamita
    Gonzalez, Paula
    Rodriguez, Paula
    Caballero, Jesus
    Barbera, Carme
    Torres, Gerard
    Labarca, Gonzalo
    Malla-Banyeres, Mar
    Moncusi-Moix, Anna
    Torres, Antoni
    de Gonzalo-Calvo, David
    Barbe, Ferran
    Gonzalez, Jessica
    Targa, Adriano D. S.
    ANNALS OF INTENSIVE CARE, 2025, 15 (01):
  • [6] Durability of Zephyr Valve treatment: 24-month follow-up in the TRANSFORM Study
    Kirk, Alan
    Slebos, Dirk-Jan
    Kornaszweska, Malgorzata
    Shah, Pallav
    Carron, Kris
    Mal, Herve
    Pison, Christophe
    Downer, Nicola
    Darwiche, Kaid
    Rao, Jagan
    Huebner, Ralf-Harto
    Trosini-Desert, Valery
    Eberhardt, Ralf
    Herth, Felix
    Derom, Eric
    Marquette, Charles
    Shargill, Narinder
    Kemp, Samuel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Effectiveness and safety of PCSK9 inhibitors in real-world clinical practice. An observational multicentre study. The IRIS-PCSK9I study
    Blanco-Ruiz, Marina
    Amaya-Pascasio, Laura
    de Torres Chacon, Reyes
    Josefa Alvarez Soria, Maria
    Arjona-Padillo, Antonio
    Carrillo Bailen, Maria Magdalena
    Milan Pinilla, Rodrigo
    Perez Ortega, Irene
    Sanchez Rodriguez, Belen
    Andrade Zumarraga, Luis
    Valverde Moyano, Roberto
    Payan Ortiz, Manuel
    Castillo Fernandez, Alba Maria
    Del Toro Perez, Cristina
    Gonzalez Bustos, Pablo
    Aguera Morales, Eduardo
    Sanchez Lopez, Purificacion
    Hidalgo Martin, Beatriz
    Roa Chamorro, Ricardo
    Fernandez Perez, Javier
    Mejias Olmedo, Maria Victoria
    Martinez-Sanchez, Patricia
    ATHEROSCLEROSIS PLUS, 2021, 45 : 32 - 38
  • [8] Comparative study of two root coverage procedures: A 24-month follow-up multicenter study
    Moses, Ofer
    Artzi, Zvi
    Sculean, Anton
    Tal, Haim
    Kozovsky, Avital
    Romanos, Georgios E.
    Nemcovsky, Carlos E.
    JOURNAL OF PERIODONTOLOGY, 2006, 77 (02) : 195 - 202
  • [9] Psychiatric disorders associated with PCSK9 inhibitors: A real-world, pharmacovigilance study
    Deng, Zhifang
    Liu, Jue
    Gong, Hongjian
    Cai, Xiaonan
    Xiao, Han
    Gao, Wenqi
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (04)
  • [10] Safety, adherence and efficacy of PCSK9 inhibitors: a retrospective real-world study
    Chng, Bee Ling Kelly
    Heng, Wei Min Paul
    Soon, Yu Ming
    Hon, Jin Shing
    Lau, Yee How
    Tan, Ru San
    Tan, Jack Wei Chieh
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2022, 31
12345